These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 1646470)

  • 1. Oleic acid as an inhibitor of gastric H+, K(+)-ATPase.
    Murakami S; Muramatsu M; Otomo S
    Res Commun Chem Pathol Pharmacol; 1991 Mar; 71(3):337-50. PubMed ID: 1646470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of gastric H+, K(+)-ATPase and acid secretion by ellagic acid.
    Murakami S; Isobe Y; Kijima H; Nagai H; Muramatu M; Otomo S
    Planta Med; 1991 Aug; 57(4):305-8. PubMed ID: 1663631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of salvianolic acid A, a depside from roots of Salvia miltiorrhiza, on gastric H+,K(+)-ATPase.
    Murakami S; Kijima H; Isobe Y; Muramatsu M; Aihara H; Otomo S; Li LN; Ai CB
    Planta Med; 1990 Aug; 56(4):360-3. PubMed ID: 2173008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AHR-9294: a novel inhibitor of H,K-ATPase antagonizes gastric HCl secretion in vivo.
    Reenstra WW; Pinkus LM; Bailey J; Smith WL; Droppleman D; Sancilio LF; Forte JG
    J Pharmacol Exp Ther; 1992 May; 261(2):737-45. PubMed ID: 1315865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of gastric H+, K(+)-ATPase by chalcone derivatives, xanthoangelol and 4-hydroxyderricin, from Angelica keiskei Koidzumi.
    Murakami S; Kijima H; Isobe Y; Muramatsu M; Aihara H; Otomo S; Baba K; Kozawa M
    J Pharm Pharmacol; 1990 Oct; 42(10):723-6. PubMed ID: 1982146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of tannic acid on gastric H+,K(+)-ATPase.
    Murakami S; Muramatsu M; Otomo S
    J Nat Prod; 1992 Apr; 55(4):513-6. PubMed ID: 1324983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of gastric antisecretory effects of nolinium bromide.
    Nandi J; Wright MV; Ray TK
    Gastroenterology; 1983 Oct; 85(4):938-45. PubMed ID: 6309605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible mechanism for the inhibition of gastric (H+ + K+)-adenosine triphosphatase by the proton pump inhibitor AG-1749.
    Nagaya H; Satoh H; Kubo K; Maki Y
    J Pharmacol Exp Ther; 1989 Feb; 248(2):799-805. PubMed ID: 2537417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological profile of novel acid pump antagonist 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methyl cyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526).
    Ito K; Kinoshita K; Tomizawa A; Inaba F; Morikawa-Inomata Y; Makino M; Tabata K; Shibakawa N
    J Pharmacol Exp Ther; 2007 Oct; 323(1):308-17. PubMed ID: 17630360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of gastric proton pump inhibition by calcium channel antagonists.
    Nandi J; King RL; Kaplan DS; Levine RA
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1102-7. PubMed ID: 2156990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible inhibition of rat gastric H+/K+-ATPase by T-330, 2-[2-dimethylaminobenzyl)sulfinyl]-1-(3-methylpyridine-2-yl)imidazole.
    Kinoshita M; Saito N; Noto T; Tamaki H
    J Pharmacol Exp Ther; 1996 Apr; 277(1):28-33. PubMed ID: 8613931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of gastric H,K-ATPase activity and gastric epithelial cell IL-8 secretion by the pyrrolizine derivative ML 3000.
    Smolka AJ; Goldenring JR; Gupta S; Hammond CE
    BMC Gastroenterol; 2004 Feb; 4():4. PubMed ID: 15028114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.
    Wallmark B; Lorentzon P; Larsson H
    Scand J Gastroenterol Suppl; 1985; 108():37-51. PubMed ID: 2988109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a relationship between activity and the tetraprotomeric assembly of solubilized pig gastric H/K-ATPase.
    Abe K; Kaya S; Taniguchi K; Hayashi Y; Imagawa T; Kikumoto M; Oiwa K; Sakaguchi K
    J Biochem; 2005 Sep; 138(3):293-301. PubMed ID: 16169880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SCH 28080 is a lumenally acting, K+-site inhibitor of the gastric (H+ + K+)-ATPase.
    Keeling DJ; Laing SM; Senn-Bilfinger J
    Biochem Pharmacol; 1988 Jun; 37(11):2231-6. PubMed ID: 2837231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A newly synthesized pyridine derivative, (Z)-5-methyl-2-[2-(1-naphthyl)ethenyl]-4-piperidinopyridine hydrochloride (AU-1421), as a reversible gastric proton pump inhibitor.
    Hioki Y; Takada J; Hidaka Y; Takeshita H; Hosoi M; Yano M
    Arch Int Pharmacodyn Ther; 1990; 305():32-44. PubMed ID: 2173509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of gastric H+,K(+)-ATPase and acid secretion by cassigarol A, a polyphenol from Cassia garrettiana Craib.
    Murakami S; Arai I; Muramatsu M; Otomo S; Baba K; Kido T; Kozawa M
    Biochem Pharmacol; 1992 Jul; 44(1):33-7. PubMed ID: 1321629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of free fatty acids and detergents on H,K-ATPase. The steady-state ATP phosphorylation level and the orientation of the enzyme in membrane preparations.
    Swarts HG; Van Uem TJ; Hoving S; Fransen JA; De Pont JJ
    Biochim Biophys Acta; 1991 Dec; 1070(2):283-92. PubMed ID: 1662535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of gastric H+,K+-transporting ATPase function by sodium.
    Ray TK; Nandi J
    FEBS Lett; 1985 Jun; 185(1):24-8. PubMed ID: 2987040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the gastric (H+ + K+)-ATPase by fenoctimine.
    Reenstra WW; Shortridge B; Forte JG
    Biochem Pharmacol; 1985 Jul; 34(13):2331-4. PubMed ID: 2990481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.